Kriti Nutrients Sep 2026 quarter: revenue rises 22%, but margin, profit and cash flow weaken
KRITINUT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated revenue from operations for the quarter ended 30 September 2026 rose 21.6% to Rs 743.30 crore from Rs 611.17 crore in the year-ago quarter. Profit after tax fell about 29% to Rs 6.50 crore from Rs 9.20 crore, and the EBITDA margin narrowed. For the six months ended 30 September 2026, consolidated operating cash flow was negative Rs 13.35 crore. The statutory auditors' limited review found no material misstatement.
Revenue growth is positive, but lower profit, a narrower margin and negative operating cash flow weaken the near-term outlook for the stock.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹231.4 Cr | ₹212.9 Cr | +8.7% |
| Operating profit | ₹6.18 Cr | ₹9.70 Cr | −36.3% |
| Profit after tax | ₹5.59 Cr | ₹8.90 Cr | −37.2% |
| EBITDA margin | 3.4% | 5.3% | −1.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.